NanoVibronix (NAOV) - Margin dodolan resik

NanoVibronix, Inc. (NAOV) utilizes patent-protected B2B technologies against catheter infections to minimize dumping, which impacts net margin fluctuations. The current level of -193.90 reflects the magnitude of this metric. Growth in hospital sales is strengthening cash flows, while management's focus on production outsourcing is currently undergoing a stage of commercial adaptation, building a moderate level of investor confidence.
Rincian metrik keuangan lan pasar NanoVibronix, Inc. (NAOV)

The indicator is based on the ratio of net income to total revenue. This metric measures the portion of income remaining with the issuer after deducting all operating and financial expenses. For NanoVibronix, Inc. (NAOV) and its UroShield product line, this reflects the monetization efficiency of ultrasound therapy. The current value of -193.90 demonstrates the business's actual ability to generate profit during its expansion phase. By analyzing the company's net margin ratio on GURU.Markets, an investor can assess the model's resilience to market volatility.